The role of salivary factors in persistent oral carriage of Candida in humans

Archives of Oral Biology

Volumn 54, Issue 7, 2009, Pages 678-683

  Hibino, Kyoko ^a   Samaranayake, Lakshman P ^a   Hägg, Urban ^a   Wong, Ricky W K ^a   Lee, Wilson ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anti candidal activity; Anti candidal salivary factors; Candida carriers and non carriers

Indexed keywords

ANTIFUNGAL AGENT; LACTOFERRIN; LYSOZYME; SECRETORY IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ARTICLE; CANDIDA; CANDIDA ALBICANS; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FUNGUS SPORE; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PH; PHYSIOLOGY; SALIVA; SECRETION;

ADOLESCENT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN A, SECRETORY; LACTOFERRIN; MALE; MURAMIDASE; SALIVA; SECRETORY RATE; SPORES, FUNGAL; YOUNG ADULT;

CANDIDA; CANDIDA ALBICANS;

EID: 67349227158     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2009.04.003     Document Type: Article

References (27)

1. In: Samaranayake L.P., and MacFarlane T.W. (Eds). Oral candidosis (1990), Wright, London
2. Sedgley C.M., and Samaranayake L.P. The oral prevalence of aerobic and facultatively anaerobic gram-negative rods and yeasts in Hong Kong Chinese. Arch Oral Biol 39 (1994) 459-466
3. Zachrisson B.U., and Zachrisson S. Gingival condition associated with partial orthodontic treatment. Acta Odontol Scand 30 (1972) 127-136
4. Zachrisson S., and Zachrisson B.U. Gingival condition associated with orthodontic treatment. Angle Orthod 42 (1972) 26-34
5. Lee W., Low B., Samaranayake L.P., and Hägg U. Genotypic variation of Candida albicans during orthodontic therapy. Front Biosci 13 (2008) 3814-3824
6. Samaranayake L.P., MacFarlane T.W., Lamey P.J., and Ferguson M.M. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Path Med 15 (1986) 386-388
7. Tobgi R., Samaranayake S.L.P., and MacFarlane T.W. In vitro susceptibility of Candida species to Lysozyme. Oral Microbiol Immunol 3 (1988) 35-39
8. Samaranayake Y.H., MacFarlane T.W., and Samaranayake L.P. The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media. Microbios 74 (1993) 23-28
9. Samaranayake Y.H., Samaranayake L.P., Pow E., and Beena N. The antifungal effect of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a HIV-infected Southern Chinese cohort. J Clin Microbiol 39 (2001) 3296-3302
10. Wu T., Samaranayake L.P., Leung W.K., and Sullivan P.A. Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme. J Med Microbiol 48 (1999) 721-730
11. Massons P., and Heremans J. Studies on lactoferrin the iron binding protein of secretions. Protein Biol Fluids 14 (1996) 115-124
12. Samaranayake Y.H., Samaranayake L.P., Wu P.C., and So M. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans. APMIS 105 (1997) 875-883
13. Xu Y.Y., Samaranayake Y.H., Samaranayake L.P., and Nikawa H. In vitro susceptibility of Candida species to lactoferrin. Med Mycol 37 (1999) 35-41
14. Nikawa H., Hayashi S., Nikawa Y., Hamada T., and Samaranayake L.P. Interactions between denture lining material, protein pellicles and Candida albicans. Arch Oral Biol 38 (1993) 631-634
15. Epstein J.B., Kimura L.H., Menard T.W., Truelove E.C., and Pearsall N.N. Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Arch Oral Biol 17 (1982) 469-474
16. Vudhichamnong K., Walker D., and Ryley H.C. The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast Candida albicans to human oral epithelial cells. Arch Oral Biol 27 (1982) 617-621
17. Lin A.L., Johnston D.A., Patterson T.F., Wu Y., Lu D.L., Shi Q., et al. Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiol Immunol 16 (2001) 270-278
18. Sugimoto J., Kanehira T., Mizugai H., Chiba I., and Morita M. Relationship between salivary histatin 5 levels and Candida CFU counts in healthy elderly. Gerodontology 23 (2006) 164-169
19. Jainkittivong A., Johnson D.A., and Yeh C.-K. The relationship between salivary histatin levels and oral yeast carriage. Oral Microbiol Immunol 13 (1998) 181-187
20. Yeh C.-K., Dodds M.J.W., Zuo P., and Johnson D.A. A population-based study of salivary lysozyme concentrations and candidal lysozyme concentrations and candidal counts. Arch Oral Biol 42 (1997) 25-31
21. Navazesh M., Christensen C., and Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 71 (1992) 1363-1369
22. Lin A.L., Shi Q., Johnson D.A., Patterson T.F., Rinnaldi M.F., and Ye C.-K. Further characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays. Clin Diagn Lab Immunol 6 (1999) 851-855
23. MacFarlane T.W., and Mason D.K. Changes in the oral flora in Sjögren's syndrome. J Clin Pathol 27 (1974) 416-419
24. Leung W.K., Dassanayake R.S., Yau J.Y., Jin L.J., Yam W.C., and Samaranayake L.P. Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors. J Clin Microbiol 38 (2000) 2219-2226
25. Lal K., Santarpia R.P., Xu L., Manssuri F., and Pollock J. One-step purification of histidine-rich polypeptides from human parotid saliva and determination of anti-candidal activity. Oral Microbiol Immunol 7 (1992) 44-50
26. Eliasson L., Birkhed D., Osterberg T., and Carlén A. Minor salivary gland secretion rates and immunoglobulin A in adults and the elderly. Eur J Oral Sci 114 (2006) 494-499
27. Sari-Sarraf V., Reilly T., Doran D., and Atkinson G. Effects of repeated bouts of soccer-specific intermittent exercise on salivary IgA. Int J Sports Med 29 (2008) 366-371